Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Resverlogix Corp

+ Add to Watchlist

RFS:GR

1.705 EUR 0.098 6.10%

As of 13:56:30 ET on 05/29/2015.

Snapshot for Resverlogix Corp (RFS)

Open: 1.578 Day's Range: 1.561 - 1.719 Volume: 0
Previous Close: 1.607 52wk Range: 0.266 - 2.285 1-Yr Rtn: +287.50%

Stock Chart for RFS

No chart data available.
  • RFS:GR 1.662
  • 1D
  • 1M
  • 1Y
1.607
Interactive RFS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RFS

Current P/E Ratio (ttm) -
Estimated P/E(04/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (04/2015) -0.1420
Est. PEG Ratio -
Market Cap (M EUR) 146.81
Shares Outstanding (M) 86.11
30 Day Average Volume 314
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RFS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RFS

Resverlogix Corp. is a biotechnology company focused on developing therapies for unmet medical needs. The Company concentrates on cardiovascular disease, cancer, and fibrotic conditions.

Donald J McCaffreyPresident/CEO/SecretaryAaron Bradley Cann "Brad"Chief Financial Officer
Norman WongChief Scientific OfficerKenneth LebiodaSenior VP:Bus & Corporate Dev
More Company Profile & Key Executives for RFS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil